Atopic Dermatitis - Drug Pipeline Landscape, 2022 | Allakos, Inc, Amgen, Amtixbio Co Ltd, Amytrx Therapeutics

Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.

Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an immune system response that causes the inflamed skin and other symptoms.

Read more about Atopic Dermatitis - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/atopic-dermatitis-drug-pipeline-landscape-2022/

Atopic dermatitis (eczema) symptoms include dry, , itchiness, rash, bumps, on brown or black skin, oozing and crusting, thickened skin, darkening of the skin around the eyes, raw, sensitive skin from scratching.

Healthcare provider will diagnose eczema examining the skin. However, the following tests may be performed for confirmation, an allergy skin test, blood tests and a skin biopsy to distinguish one type of dermatitis from another.

Treatment of atopic dermatitis starts with moisturizing and self-care habits. These are sometimes combined with other treatments like medications and therapies. Medications including products applied to the skin, anti-infective drugs and anti-inflammatories. Therapies like wet dressings, light therapy and counselling may also help based on the severity.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS31002

Key Players
• 3SBio Inc
• AbbVie
• Aclaris Therapeutics, Inc.
• Akaal Pharma Pty Ltd
• Akesobio Australia Pty Ltd
• Allakos, Inc.
• Amgen
• Amtixbio Co Ltd
• Amytrx Therapeutics, Inc
• AOBiome LLC
• Arcutis Biotherapeutics, Inc.
• Arena Pharmaceuticals

Report Segmentation
Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS31002

Report Highlights
Global Insight Service's, Atopic Dermatitis - Drug Pipeline Landscape, 2022 report provides an overview of the Atopic Dermatitis pipeline drugs. This report covers detailed insights on Atopic Dermatitis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Atopic Dermatitis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Get a 50% Off on Purchase of this Report Use Code (GIS2022SUP50) : https://www.globalinsightservices.com/checkout/single_user/GIS31002

With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.

This release was published on openPR.